Wednesday, August 10, 2016
Oncolytics Biotech® Inc. Reports Additional Data from Randomized Phase II Study of REOLYSIN® in Non-Small Cell Lung Cancer
… advanced or metastatic non-small cell lung cancer. Patients with squamous cell histology … % to 85% of lung cancer cases are non-small cell lung cancer. The ACS identifies multiple subtypes of non-small cell lung cancer based …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment